U.S. Retail Distributors Stock News

Earlier this month, Astec Industries reported quarterly results showing revenue up 20.3% year on year, driven by strong growth in its Materials Solutions segment while Infrastructure Solutions sales were flat and adjusted operating income missed analyst expectations. Shortly after, management’s appearance at the Wells Fargo Industrials & Materials Conference gave investors more detail on why robust sales have not yet translated into stronger operating profitability and cash generation. We’ll...

Supply chain relief and MYR Group’s latest move Signals of a possible resolution to the three month supply chain disruption linked to the Strait of Hormuz have lifted sentiment, with MYR Group (MYRG) climbing about 5% as cyclical stocks broadly rallied. See our latest analysis for MYR Group. Beyond today’s move, MYR Group’s share price has a 90 day return of 66.7% and a year to date share price return of 96.6%. The 1 year total shareholder return of 172.8% points to strong momentum that has...

Sezzle (SEZL) has rolled out a wide range of new tools, from its Earn rewards tab and Pay in 5 plans to an AI-powered support chatbot and Sezzle Mobile phone service. See our latest analysis for Sezzle. Sezzle’s recent product rollouts and AI push come as momentum in the stock has been strong, with a 90 day share price return of 98.65% and a year to date share price return of 103.68%, even though the 1 year total shareholder return is slightly down 0.63% from a year ago. If you are looking...

In June 2026, Q2 Holdings launched Second Quarter Assistant, a unified, context-aware AI experience layer embedded across its digital banking platforms for banks and credit unions, initially featuring a Customer Care Agent to help resolve common support issues within Q2’s Console. An interesting aspect is that Second Quarter Assistant is built to meet regulated institutions’ governance needs, keeping customer data isolated and encrypted while logging all interactions and reserving...

Artificial intelligence is no longer a niche story; it now sits at the centre of global trade, powering 43% of trade growth while still only 15% of overall volume. Trade in AI-related hardware grew over 20% in the first half of 2025, even as wider goods trade stayed closer to 4% growth and global export growth is expected to cool in 2026. For investors, that mix of strength and friction can reward companies with scale, quality and real AI exposure. This article looks at 3 stocks from our...

Geopolitics is back in the spotlight, and energy markets are feeling it. With the U.S.-Iran peace deal under pressure, renewed tensions around the Strait of Hormuz are raising questions about supply security and price risk that can ripple through your portfolio. Instead of reacting to headlines alone, it can help to focus on large, financially solid oil and gas producers that sit at the center of this story. This article highlights 3 stocks from our Energy Sector screener that appear...

Envista Holdings (NVST) stock overview Envista Holdings (NVST) has been drawing attention after recent share price moves, with the stock last closing at US$24.60 and showing mixed returns over the past year and past 3 months. See our latest analysis for Envista Holdings. The recent 7 day share price return of 6.49% builds on a 30 day gain of 5.94%, yet the 3 year total shareholder return is down 26.50%. This highlights short term momentum compared with a weaker longer record. If Envista’s...

Earlier this month, Construction Partners, Inc. amended its Term Loan A / Revolver Credit Agreement, lifting its revolving credit facility from US$500 million to US$700 million and loosening certain financial and negative covenants across interest coverage, leverage, acquisitions, and subsidiary guarantees. The amendment meaningfully broadens the company’s financial toolkit, giving it more room to fund acquisitions, infrastructure projects, and share repurchases while managing leverage...

Recent analyst upgrades for Relay Therapeutics (RLAY) focus on early clinical data for its drug candidate zovegalisib. Initial results in PIK3CA-driven vascular anomalies, particularly in heavily treated patients, have drawn increased attention to the stock. See our latest analysis for Relay Therapeutics. The recent enthusiasm around zovegalisib comes on top of strong price momentum, with a 1-month share price return of 21.39%, a 3-month share price return of 46.20% and a year-to-date share...

CenterPoint Energy (CNP) stock has been drawing fresh attention after recent share price moves, with investors weighing its performance over the past month and past 3 months against its longer term track record. See our latest analysis for CenterPoint Energy. The stock’s recent 1 month share price return of 3.3% and year to date share price return of 10.77% sit alongside a 1 year total shareholder return of 20.61%, suggesting that momentum has been building over time. If you are looking...

In recent weeks, BlackRock expanded its presence in digital and thematic investing by highlighting strong inflows into its iShares Bitcoin Trust ETF, advancing tokenized versions of its stock on crypto platforms, and launching a new space-focused ETF for European and UK investors that tracks the STOXX Global Space Satellites and Drones Index. This combination of blockchain-linked products and space-focused funds shows how BlackRock is reshaping its product mix around emerging themes such as...

In early June 2026, Hamilton Wingo filed the first wrongful death lawsuit in Dallas County Court at Law against Atmos Energy and several other parties over a fatal gas explosion that destroyed The Clyde apartment complex in Oak Cliff, killing three residents including 81-year-old community activist Sylvia Collins. The filing raises material questions about Atmos Energy’s gas line safety practices and potential liability, particularly given reports that residents smelled gas for days before...

Globant (GLOB) drew fresh attention after announcing that United States Men's National Soccer Team head coach Mauricio Pochettino will rely on its Sportian Performance platform for tournament tactics and match analysis using AI driven data tools. See our latest analysis for Globant. Despite the Sportian announcement drawing fresh attention to Globant's AI capabilities in sports, the stock's recent momentum has been weak, with the 30 day share price return down 3.65% and the year to date share...

Hertz Global Holdings (HTZ) is back in focus after weakening revenue trends, a sharp decline in return on invested capital, and short interest at 43.49% of float intensified investor caution around the stock. See our latest analysis for Hertz Global Holdings. At a share price of $5.13, Hertz’s recent 29.22% 3 month share price return contrasts with a year to date share price return that is down 1.72% and a 1 year total shareholder return that is down 12.61%. This suggests near term momentum...

Short term moves and longer term context for Trupanion Trupanion (TRUP) has caught investor attention after recent price strength, with the stock up about 7.5% over the past week and roughly 6% over the past month, contrasting with a decline of about 6.7% over the past 3 months. See our latest analysis for Trupanion. That recent pick up in momentum sits against a weaker backdrop, with the share price down 36.42% year to date and the 1 year total shareholder return declining 53.47% despite the...

Fortive stock snapshot Fortive (FTV) has drawn investor attention after recent trading, with the stock last closing at US$60.14. Price moves sit against multi-year total returns and ongoing revenue and net income growth for the company. See our latest analysis for Fortive. Recent trading has been choppy, with a 1-day share price return of 0.5% and a 7-day decline of 1.9%. However, the 90-day share price return of 11.9% and 1-year total shareholder return of 15.4% point to momentum that has...

In May 2026, ICU Medical’s Vice President and General Counsel, Virginia Ruth Sanzone, sold 2,447 shares, about 11.17% of her direct holdings, while the Smiths Medical integration neared completion with manufacturing consolidation largely finished and new pump lines in development. At the same time, Madison Small Cap Fund disclosed a new position in ICU Medical, highlighting the company’s infusion therapy focus, market share gains amid competitors’ quality issues, and a high-volume connected...

Macy's stock performance and recent context Macy's (M) stock has recently attracted attention after a strong stretch of returns, including gains over the past week, month, and past 3 months. This performance has prompted investors to reassess the department store retailer's valuation and fundamentals. See our latest analysis for Macy's. At a share price of $25.37, Macy's recent momentum is strong, with a 30 day share price return of 37.81% and a 1 year total shareholder return of 132.50%...

Dollar Tree recently reported past Q1 2026 results showing net sales growth, higher comparable-store sales, a large adjusted EPS increase, and nearly US$600 million in share repurchases, alongside raising its full-year adjusted EPS guidance. Beneath the strong headline figures, Dollar Tree’s expanding multiprice assortment and growing appeal to higher-income beauty shoppers highlight a meaningful shift in its customer mix and profit drivers. We’ll now examine how Dollar Tree’s upgraded...

Earlier this month, Diehl Defence announced it had signed a Memorandum of Understanding with Spire Global at the ILA Berlin Airshow 2026 to explore collaboration on satellite-based intelligence and early warning against ballistic and hypersonic missiles, drawing on Spire’s RF detection and analytics capabilities. This collaboration framework, paired with Spire’s new Munich facility capable of producing up to 100 satellites per year, highlights how the company is positioning itself as a...

Earlier this month, MiniMed announced an expanded agreement with Abbott to commercialize Abbott’s CE‑marked dual glucose–ketone Libre Duo sensors in Europe, while Abbott’s board approved its 410th consecutive quarterly dividend of US$0.63 per share payable on August 17, 2026. This combination of long-running dividend continuity and first-of-its-kind dual-analyte diabetes technology underscores how Abbott is pairing cash returns with ongoing innovation in chronic disease management. We’ll now...

In recent weeks, Roper Technologies has drawn fresh attention from institutional investors and analysts, who highlighted its resilient portfolio of vertical software and technology‑enabled businesses, robust free cash flow, and shareholder‑friendly policies such as double‑digit dividend growth and active share repurchases. At the same time, ongoing strength in its Technology Enabled Products segment and enhancements like DAT Freight & Analytics’ expanded reloads feature are reinforcing the...

Conference spotlight puts CBIZ in focus CBIZ (CBZ) is back in the spotlight after presenting at the 46th Annual William Blair Growth Stock Conference in Chicago, drawing attention to a stock that has been rebounding from long term lows. Recent coverage links the move in CBIZ shares to improving technical signals, a wide gap to some valuation estimates, and insider buying, while still flagging risks around AI disruption concerns and acquisition related leverage. See our latest analysis for...

Insperity (NSP) has been in focus after its latest quarterly update, where Q1 revenue of US$1.90b aligned with expectations but full year EPS guidance fell short, prompting a 2.4% share price decline. See our latest analysis for Insperity. Beyond the immediate reaction to earnings, Insperity’s share price has climbed 21.07% over the past 30 days and 68.51% over 90 days, while the 1 year total shareholder return is down 34.90%. This suggests that recent momentum contrasts with a weaker longer...